SOLARANSE8 May 2025

Solara Active Pharma Sciences Limited has informed the exchange regarding the conference call scheduled with the investors and analysts on Thursday, May 15, 2025 at 3:30 PM to discuss the Company's Fi...

Solara Active Pharma Sciences Limited

Communication Address: Solara Active Pharma Sciences Limited TICEL BIO PARK., 6th floor

Module No. 601, 602, 603, Phase II – CSIR Road, Taramani, Chennai, Tamil Nadu – 600113.

Tel: +91 44 47406200 Fax: +91 44 47406190 E-mail: investors@solara.co.in www.solara.co.in

May 08, 2025

The BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Mumbai – 400 001

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E), Mumbai – 400 051

Scrip Code: 541540, 890202

Scrip Code: SOLARA, SOLARAPP

Dear Sir / Madam,

Subject: Intimation of Analysts / Institutional Investors Conference Call

Pursuant to Regulation 30 and Para A of Part A of Schedule III and Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, kindly note that the Company, as part of investors engagement activities, has scheduled a conference call with the investors and analysts on Thursday, May 15, 2025, at 3:30 pm IST to discuss the Company’s financial results for the quarter and year ended March 31, 2025. The conference call details are as follows:

Event

Post Results Q4 FY25 Conference Call

Date & Time Thursday, May 15, 2025, at 3:30 pm IST

Phone Numbers

+91 22 6280 1346 +91 22 7115 8247

URL for prior (early) registration https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=8247933&linkSec urityString=3a33611c57

This is for your information and records.

Thanking you, Yours faithfully, For Solara Active Pharma Sciences Limited

S. Murali Krishna Company Secretary

Solara Active Pharma Sciences Limited - CIN: L24230MH2017PLC291636

REGD. OFF: ‘Cyber One’, Unit No. 902, Plot No. 4 & 6, Sector 30A, Vashi, Navi Mumbai - 400 703

Solara Conference Call Thursday, 15th May 2025, 3:30 pm IST

Pure play APIs.

SOLARA ACTIVE PHARMA SCIENCES | May’25

Arun Kumar, Founder & Non-Executive Director Sandeep Rao, MD & CEO Sarat Kumar, CFO

Dial in Details:

For Solara’s conference call, Thursday 15th May 2025, 3:30 pm IST

Universal Access

DiamondPass (for early registration)

+91 22 6280 1346 +91 22 7115 8247

Click here

1

← All TranscriptsSOLARA Stock Page →